Chong Kun Dang Pharmaceutical (XKRX:185750) Change In Receivables : ₩438 Mil (TTM As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Chong Kun Dang Pharmaceutical Change In Receivables?

Chong Kun Dang Pharmaceutical's change in receivables for the quarter that ended in Mar. 2024 was ₩35,836 Mil. It means Chong Kun Dang Pharmaceutical's Accounts Receivable declined by ₩35,836 Mil from Dec. 2023 to Mar. 2024 .

Chong Kun Dang Pharmaceutical's change in receivables for the fiscal year that ended in Dec. 2023 was ₩-29,450 Mil. It means Chong Kun Dang Pharmaceutical's Accounts Receivable increased by ₩29,450 Mil from Dec. 2022 to Dec. 2023 .

Chong Kun Dang Pharmaceutical's Accounts Receivable for the quarter that ended in Mar. 2024 was ₩245,764 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Chong Kun Dang Pharmaceutical's Days Sales Outstanding for the three months ended in Mar. 2024 was 62.04.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Chong Kun Dang Pharmaceutical's liquidation value for the three months ended in Mar. 2024 was ₩128,817 Mil.

Chong Kun Dang Pharmaceutical Change In Receivables Historical Data

The historical data trend for Chong Kun Dang Pharmaceutical's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chong Kun Dang Pharmaceutical Change In Receivables Chart

Chong Kun Dang Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

12,506.07

-22,597.29

-6,953.54

-51,446.35

-29,450.23

Chong Kun Dang Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															5,947.67	3,560.96	-18,478.25	-20,480.61	35,835.84

Chong Kun Dang Pharmaceutical Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩438 Mil.

Chong Kun Dang Pharmaceutical (XKRX:185750) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Chong Kun Dang Pharmaceutical's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	245763.718	/	361502.276	*	91
=	62.04

2. In Ben Graham's calculation of liquidation value, Chong Kun Dang Pharmaceutical's accounts receivable are only considered to be worth 75% of book value:

Chong Kun Dang Pharmaceutical's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	393304.638	-	588330.999	+	0.75 * 245763.718	+	0.5 * 279040.729
=	128,817

Chong Kun Dang Pharmaceutical Change In Receivables Related Terms

Thank you for viewing the detailed overview of Chong Kun Dang Pharmaceutical's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Chong Kun Dang Pharmaceutical (XKRX:185750) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chong Kun Dang Pharmaceutical Corp (XKRX:185750) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

368 Chungjungro-3Ga, Seodaemun-gu, Seoul, KOR, 120-756

Website

http://chongkundang.en.ec21.com

Chong Kun Dang Pharmaceutical Corp. is a manufacturer of antibiotics. The company manufactures and distributes over 130 ethical, OTC pharmaceuticals and pharmaceutical active ingredients, primarily focusing on the application of its advanced technologies in fermentation and organic synthesis. The product range includes Rifampicin (antituberculosis), DMCT (raw material for Minocycline), Cephalosporins, 7-ACA and other intermediates of Cephalosporins, Cyclosporin A (immunosuppressant) and Lovastatin (antihyperlipidaemic agent).

Chong Kun Dang Pharmaceutical (XKRX:185750) Headlines

No Headlines